About UPF0415 protein C7orf25
UPF0415 protein C7orf25 (C7orf25) is a protein
from Homo sapiens identified by UniProt accession
Q9BPX7, 421 residues long.
MolForge cross-references it against 0 known binders and
20 disease associations.
Target properties
| Protein name | UPF0415 protein C7orf25 |
| UniProt accession | Q9BPX7 |
| Gene | C7orf25 |
| Organism | Homo sapiens |
| Length | 421 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (20)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.37
- BMI-adjusted waist-hip ratio · score 0.24
- body height · score 0.23
- heel bone mineral density · score 0.23
- BMI-adjusted waist circumference · score 0.22
- cortical surface area measurement · score 0.22
- neuroimaging measurement · score 0.21
- body fat percentage · score 0.21
- protein measurement · score 0.19
- bone quantitative ultrasound measurement · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BPX7-F1 | alphafold | PREDICTED | 89.65 | — |
Amino-acid sequence (421 residues)
MSAHSMLCER IAIAKELIKR AESLSRSRKG GIEGGAKLCS KLKAELKFLQ KVEAGKVAIK ESHLQSTNLT HLRAIVESAE NLEEVVSVLH VFGYTDTLGE KQTLVVDVVA NGGHTWVKAI GRKAEALHNI WLGRGQYGDK SIIEQAEDFL QASHQQPVQY SNPHIIFAFY NSVSSPMAEK LKEMGISVRG DIVAVNALLD HPEELQPSES ESDDEGPELL QVTRVDRENI LASVAFPTEI KVDVCKRVNL DITTLITYVS ALSYGGCHFI FKEKVLTEQA EQERKEQVLP QLEAFMKDKE LFACESAVKD FQSILDTLGG PGERERATVL IKRINVVPDQ PSERALRLVA SSKINSRSLT IFGTGDTLKA ITMTANSGFV RAANNQGVKF SVFIHQPRAL TESKEALATP LPKDYTTDSE H
Explore UPF0415 protein C7orf25 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets